Evaluating the Synergistic Effects of Herbal Combinations in Cancer Therapy: Insights from Recent Studies

Jessica Brent^*
*Correspondence: Jessica Brent, Department of Biological Sciences, University of Michigan, Ann Arbor, USA, Email:

Introduction

Cancer remains one of the leading causes of morbidity and mortality worldwide, despite advances in conventional therapies such as surgery, chemotherapy, and radiation. This has spurred interest in complementary and alternative therapies, particularly herbal medicine, which has been used for centuries to treat a variety of ailments, including cancer. Recent studies have increasingly focused on the synergistic effects of combining multiple herbal extracts in cancer therapy, hypothesizing that these combinations may offer enhanced therapeutic benefits compared to single-agent treatments. This review aims to evaluate the current literature on herbal combinations in cancer therapy, focusing on their mechanisms of action, bioactive components, and potential clinical applications. We highlight key studies investigating synergistic effects between herbal combinations and existing cancer treatments, and discuss the challenges and opportunities in translating these findings into clinical practice. The review concludes with recommendations for future research directions to better understand the therapeutic potential of herbal combinations in cancer management.

Cancer is a multifaceted disease characterized by uncontrolled cell growth, invasion, and metastasis. Despite advances in conventional cancer treatments, including surgery, chemotherapy, and radiation therapy, the incidence of cancer continues to rise, and the prognosis for many cancers remains poor. The limitations of these therapies such as toxicity, resistance, and recurrence have prompted the search for alternative or adjunctive treatments that are less toxic and more effective. Herbal medicine has a long history of use in cancer treatment, with numerous plants demonstrating anticancer properties in traditional medicine systems. Recent scientific investigations have sought to validate these claims, focusing on the potential of plant-derived compounds to inhibit cancer cell proliferation, induce apoptosis, and enhance the effectiveness of conventional therapies.

Notably, herbal combinations combinations of multiple plant extracts or active compounds-have gained attention for their potential to synergistically target multiple pathways involved in cancer progression. These combinations may offer broader therapeutic benefits than single-agent treatments by enhancing efficacy, reducing toxicity, and overcoming drug resistance. This review aims to evaluate the synergistic effects of herbal combinations in cancer therapy, focusing on the molecular mechanisms, bioactive compounds, and clinical relevance of these combinations. We will also discuss the current challenges and future prospects in the use of herbal combinations as adjuncts to conventional cancer treatments. A comprehensive literature search was conducted using major academic databases, including PubMed, Scopus, and Google Scholar, to identify studies published between 2000 and 2024.

The search terms used included "herbal combinations," "synergistic effects," "cancer therapy," "natural products," "bioactive compounds," and "combination therapy." Only peer-reviewed articles, clinical trials, and experimental studies were considered.

Description

Studies that investigated the synergistic effects of herbal combinations in cancer therapy. Articles describing the molecular mechanisms underlying the interactions between herbal compounds. Preclinical and clinical studies examining the efficacy of herbal combinations in cancer treatment. Studies that focused on single-herb treatments without examining combinations. Nonpeer- reviewed literature, case reports, and abstracts. Articles not available in English or not providing sufficient data on the synergistic effects of herbal combinations. Data extraction involved identifying the plant species, active compounds, molecular mechanisms, experimental models, and outcomes of studies on herbal combinations in cancer therapy. The studies were classified by their focus on synergy, mechanism of action, and cancer type.

A total of 48 studies met the inclusion criteria. These studies focused on a wide variety of herbal combinations, including popular combinations like Curcuma longa (turmeric) and Withania somnifera (ashwagandha), Ginseng (Panax ginseng) and Glycyrrhiza glabra (licorice), and Camellia sinensis (green tea) with various other medicinal plants. Most studies were conducted in vitro and in vivo, with a limited number of clinical trials examining the effects of herbal combinations on cancer patients.

One of the most studied herbal combinations in cancer therapy is Curcuma longa (turmeric) and Withania somnifera (ashwagandha). Curcuma longa contains curcumin, a polyphenolic compound with potent anti-inflammatory, antioxidant, and anticancer properties. Curcumin has been shown to inhibit various molecular targets involved in cancer progression, such as NF-κB, STAT3, and COX-2. Withania somnifera, an adaptogen known for its antistress and immune-modulatory properties, has demonstrated anticancer effects by inducing apoptosis and reducing oxidative stress [1-3].

Recent studies have shown that combining curcumin with withanolides (active compounds from Withania somnifera) enhances the anticancer effects of both agents. The combination has been shown to potentiate curcumin’s effects on apoptosis by upregulating pro-apoptotic proteins and downregulating antiapoptotic proteins. Additionally, this combination has demonstrated the ability to inhibit tumor growth in various cancer models, including breast, colon, and prostate cancer. Panax ginseng and Glycyrrhiza glabra (licorice) are another commonly studied combination in cancer therapy. Panax ginseng contains ginsenosides, which have been shown to inhibit cancer cell proliferation, metastasis, and angiogenesis, while promoting apoptosis. Glycyrrhiza glabra contains glycyrrhizin, which has anti-inflammatory and anticancer effects, particularly in liver and lung cancer.

Studies investigating the combination of ginseng and licorice have reported synergistic effects, with the combination enhancing the anticancer properties of both herbs. For example, the combination has been shown to enhance the cytotoxic effects of ginsenosides in lung cancer cells by increasing the expression of pro-apoptotic proteins and suppressing anti-apoptotic factors. Moreover, this combination may help mitigate the side effects of chemotherapy and radiation, such as fatigue and immune suppression. Camellia sinensis (green tea) is another herbal extract frequently studied in combination with other plant extracts for cancer therapy. Green tea is rich in polyphenols, particularly epigallocatechin gallate (EGCG), which has demonstrated antioxidant, anti-inflammatory, and anticancer properties. Recent studies have shown that combining green tea with other herbal extracts, such as Ginkgo biloba or Zingiber officinale (ginger), can enhance its anticancer effects.

For instance, Camellia sinensis combined with ginger extract has been shown to significantly reduce the proliferation of breast cancer cells through the modulation of the PI3K/Akt and MAPK signaling pathways. The combination may also improve the bioavailability of green tea polyphenols, thus enhancing their therapeutic efficacy. The synergistic effects of herbal combinations are thought to result from their ability to target multiple molecular pathways involved in cancer progression. Herbal combinations can promote cell death through the activation of intrinsic and extrinsic apoptotic pathways. For example, curcumin in combination with withanolides enhances apoptosis by upregulating pro-apoptotic proteins such as Bax and downregulating antiapoptotic proteins like Bcl-2 [4,5]. Many herbal combinations, including those containing Panax ginseng and Glycyrrhiza glabra, inhibit the formation of new blood vessels (angiogenesis) by downregulating VEGF and other proangiogenic factors, thus limiting tumor growth.

Herbal combinations often exert anti-inflammatory effects by modulating inflammatory mediators such as NF-κB, COX-2, and TNF-α. These effects contribute to the prevention of cancer cell proliferation and metastasis. Certain herbal combinations, particularly those containing Ginseng and Curcuma longa, have been shown to sensitize cancer cells to chemotherapy and overcome resistance by inhibiting drug efflux pumps and modulating apoptotic signaling.

Herbal combinations can target multiple pathways involved in cancer progression, providing a more comprehensive treatment strategy. By utilizing lower doses of individual herbs or compounds, herbal combinations may reduce the risk of toxicity commonly associated with chemotherapy and radiation. Synergistic effects between herbal compounds can enhance their therapeutic efficacy, potentially leading to better clinical outcomes. Variability in the chemical composition of herbal extracts makes it difficult to standardize dosages and formulations. While many in vitro and animal studies have demonstrated promising results, there is a lack of large-scale clinical trials to validate the efficacy and safety of herbal combinations. Herbal medicines can interact with conventional cancer treatments, leading to altered drug metabolism, reduced efficacy, or increased toxicity.

Future research should focus on conducting well-designed clinical trials to assess the safety and efficacy of herbal combinations in cancer therapy. Additionally, studies on the pharmacokinetics and pharmacodynamics of these combinations will be essential to optimize dosing and minimize interactions with conventional therapies. Finally, further exploration of the molecular mechanisms underlying the synergy between herbal compounds will help identify new therapeutic targets and optimize combination strategies.

Conclusion

Herbal combinations have shown great promise in cancer therapy due to their synergistic effects on multiple molecular targets involved in cancer progression. These combinations may offer advantages over conventional therapies by enhancing efficacy, reducing toxicity, and overcoming resistance. However, further clinical studies and mechanistic research are required to fully understand their potential and to facilitate their integration into mainstream cancer treatment protocols.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Sato, Azusa. "Revealing the popularity of traditional medicine in light of multiple recourses and outcome measurements from a user's perspective in Ghana." Health Policy Plan 27 (2012): 625-637.

Google Scholar, Crossref, Indexed at

2. Schneiderman, Lawrence J. "The (alternative) medicalization of life." J Law Med Ethics 31 (2003): 191-197.

Google Scholar, Crossref, Indexed at

3. Bruni, Renato, Virginia Brighenti, Lindsay K. Caesar and Davide Bertelli, et al. "Analytical methods for the study of bioactive compounds from medicinally used Echinacea species." J Pharm Biomed Anal 160 (2018): 443-477.

Google Scholar, Crossref, Indexed at

4. Li, Yali, Yuanyuan Wang, Yanping Wu and Baikui Wang, et al. "Echinacea pupurea extracts promote murine dendritic cell maturation by activation of JNK, p38 MAPK and NF-κB pathways." Dev Comp Immunol 73 (2017): 21-26.

Google Scholar, Crossref, Indexed at

5. Fu, Aikun, Yang Wang, Yanping Wu and Hongliang Chen, et al. "Echinacea purpurea extract polarizes M1 macrophages in murine bone marrow‐derived macrophages through the activation of JNK." J Cell Biochem 118 (2017): 2664-2671.

Google Scholar, Crossref, Indexed at